Treatment and Prevention Research for SARS-CoV-2
We are working with researchers around the world on the fight against SARS-CoV-2, with dedicated testing kits and solutions to better study and understand viruses, as well as technology to automate and speed workflows.
For research use only. Not for use in diagnostic procedures.
Explore Our SARS-CoV-2 Testing Solutions for Research
The PerkinElmer chemagic™ Viral DNA/RNA 300 H96 Kit using the chemagic™ 360 instrument deliver fast, high throughput isolation of viral RNA for subsequent SARS-CoV-2 analysis. The isolation process for up to 96 samples/run takes just 60 minutes and only 31 minutes with an optimized short protocol. The eluted viral RNA is ready for subsequent analysis via RT-PCR or NGS.
Scalable and modular explorer™ automated workstations maximize the efficiency of SARS-CoV-2 RT-PCR or ELISA testing.
The recent outbreak of coronavirus (SARS-CoV-2) has highlighted the need for technologies to support rapid, high-throughput testing of biological samples.
* Products may not be licensed in accordance with the laws in all countries. Please check with your local representative for availability.
The COVID-19 outbreak in December 2019 resulting from the human coronavirus SARS-CoV-2 has been spreading rapidly throughout the world and has impacted the daily lives of hundreds of millions of people worldwide.
NGS workflows can be used to detect SARS-CoV-2 virus, perform surveillance and epidemiological studies, track mutational changes in the virus, enable unbiased pathogen discovery, and analyze potential susceptibility and human response to SARS-CoV-2 infection.
Streamline surface testing of SARS-CoV-2 with an automated workflow using the PerkinElmer® SARS-CoV-2 Nucleic Acid Detection Kit for Environmental Surfaces or take a simplified, direct approach by moving from sample to PCR with the DirectDetect™ SARS-CoV-2 Real-time RT-PCR kit for Environmental Surfaces
Elisa Vicenzi, PhD
Maria De Lorenzis
In the last 18 years, the coronavirus disease arose at the end of 2019 is the third sever outbreak originated by a Coronavirus. What is it known as of today about SARS-CoV-2 virus? What’s the origin and how is it changing to adapt to human population? Join our webinar to learn more about the genetic discoveries of SARS-CoV-2 virus.
Lidia Pieri, PhD
Maria De Lorenzis
The folding of proteins is an interesting target for drug development that requires structural and conformational analysis of the proteins. One of the challenges in this field is the ability to predict the structure of polypeptide and full proteins. Sybilla Biotech has successfully used new algorithms implemented to the Pharmacological Protein Inactivation by Folding Intermediates Targeting (PPI-FIT) drug discovery approach. Join our webinar to learn more about how this approach has been used to study the folding of ACE2 of SARS-CoV-2 virus.
Market Development Manager - NGS
Maria De Lorenzis
Viruses are known to be able to change frequently their genome to be able to adapt to environmental pressure and persist in their infective action. Next generation sequencing is highly used to understand such changes and determine the origin and the evolution of the virus. Join our webinar to gain an overview of how NGS is applied in the virus study and how PerkinElmer can help in the NGS application.
Veronique Berchet PhD
Maria De Lorenzis
High content screening (HCS) is frequently used to study the phenotype changes of cells under different experimental conditions and to collect physiological relevant data about the cells. It is commonly used in virology research as well to understand the mechanism of action of virus when infecting cells and to screen for compounds that can inhibit such interactions. Join our webinar to learn more about how HCS can be applied in the research around SARS-CoV-2 research and how PerkinElmer can help in this field.
Automation has helped many labs keep pace with new and increasing demands brought on by COVID-19. In this article, our Global Director of Automated Solutions Carola Schmidt shares advice on how to setup new technology initiatives for success.Read More
One takeaway from COVID-19 is that understanding the mechanisms of viral evolution can help track variants in real time. Arvind Kothandaraman, our general manager of specialty diagnostics, explains how new and emerging technologies have enabled scientists and research to identify and monitor SARS-CoV-2 mutations.Read More
Next-generation sequencing (NGS) plays a vital role in COVID-19 surveillance. Our General Manager of NGS Michelle Fraser shares her thoughts on the latest advances in NGS technology and the global effort to track the virus and its variants.Read More
Euroimmun launches SARS-CoV-2 NeutraLISA Assay to Determine the Neutralizing Capacity of Anti-SARS-CoV-2 Antibodies
EUROIMMUN announced the SARS-CoV-2 NeutraLISA assay, a surrogate neutralization test for detecting neutralizing antibodies against SARS-CoV-2. This assay is now CE marked in over 30 countries.Read More
The latest RUO solutions, PKamp™ VariantDetect™ SARS-CoV-2 RT-PCR Assay and Next Generation Sequencing-based NEXTFLEX® Variant-Seq™ SARS-CoV-2 Kit, extends PerkinElmer’s testing portfolio to known and unknown variants.
The global COVID-19 pandemic caused by the coronavirus SARS-CoV-2 is anticipated to continue, even as countries put strict measures in place to flatten the curve in an attempt to avoid overwhelming healthcare systems. Labs are implementing high-throughput nucleic acid testing to detect viral sequences in suspected patients and are ramping up to meet the demands of population testing.Read More
WALTHAM, Mass. – January 14, 2021 – PerkinElmer today announced that its EUROIMMUN business has launched a SARS-CoV-2 Interferon Gamma Release Assay (IGRA) for Research Use Only (RUO) to determine the activity of T-cells reactive to SARS-CoV-2, the pathogen causing COVID-19.Read More
PerkinElmer Launches COVID-19 Environmental Surface Testing Kits to Help Food Processors and Contract Labs Detect Presence of Virus in Facilities
PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today introduced two COVID-19 environmental testing kits to help food processors and contract labs detect the presence of SARS-CoV-2 on surfaces in food plants such as plastic, ceramic and stainless steel.Read More
PerkinElmer Launches Modular and Scalable explorer™ Workstations for High-throughput COVID-19 Detection
WALTHAM, Mass.--(BUSINESS WIRE)--Aug. 17, 2020-- PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced the launch of a series of explorer™ workstations for SARS-CoV-2 testing capable of preparing and running up to 10,000 COVID-19 tests per day. These modular and scalable workstations enable laboratories to ramp up SARS-CoV-2 testing capacity quickly to generate results.Read More
PerkinElmer Launches Online, Open Access COVID-19 Data Dashboards to Accelerate Antiviral Therapeutics Research
WALTHAM, Mass. -- July 22, 2020 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that it has launched two online, free-access PerkinElmer COVID-19 Data Dashboards to help the global scientific community accelerate the discovery of COVID-19 antivirals and vaccines.Read More
Increase Throughput and Reduced Variability of Virus Plaque Assays with Automated Imaging and Analysis with the EnSight Application Note
Plaque Assays are a standard method utilized by virologists to determine the concentration of viruses in solution.Read More
Viruses rely heavily on interactions with their host to sustain their life cycle. For this reason, several steps of this cycle have long been considered desirable targets for assay development and drug discovery.Read More
Influenza is a highly infectious airborne disease with an important societal burden. Annual epidemics have occurred throughout history causing tens of millions of deaths.Read More
Infectious diseases remain a major burden to human health. The increased globalization of modern society that facilitates the spread of infectious diseases, and phenomena such as anti-microbial resistance, underscore the importance of the development of new preventative and therapeutic approaches.Read More
High-Throughput DNA Quantification for Next Generation Sequencing on the VICTOR Nivo Application Note
Next generation sequencing (NGS) library preparation requires accurate quantification of the genomic DNA (gDNA) starting material to begin the workflow. After library preparation, dsDNA library quantification may also be necessary prior to sequencing.Read More